RPL13AP

Across TCGA pan-cancer cohorts, RPL13AP RNA is linked to patient survival in 16 of 34 cancer types, making it the most broadly survival-associated RPL13AP data layer.

The strongest signal is observed in rectum adenocarcinoma (READ), where higher RPL13AP RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated RPL13AP expression acts as an unfavorable survival marker, although some lineages such as READ and THCA show a favorable association.

READ, CHOL, and ACC are the cancer types where RPL13AP RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
READ	DFS	Quartile	All	0.845	0.484	.003	78	view →
CHOL	DFS	Tertile	III,IV	0.031	0.505	.003	45	view →
ACC	OS	Tertile	III,IV	0.324	0.673	.018	39	view →
THCA	DFS	Tertile	All	0.969	0.746	.027	25	view →
KIRC	DFS	Median	IV	0.459	0.255	.010	22	view →
LGG	DFS	Median	All	0.327	0.476	.014	14	view →
GBM	OS	Tertile	All	0.480	0.356	.025	12	view →
DLBC	OS	Tertile	II,III,IV	0.294	1.000	.023	10	view →
ESCA	DFS	Median	All	0.276	0.425	.011	9	view →
OV	OS	Tertile	III,IV	0.632	0.713	.039	6	view →
UCEC	OS	Tertile	II,III,IV	0.792	0.868	.034	4	view →
SKCM	OS	Median	IV	0.621	0.140	.044	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 16 lineages.

RPL13AP–READ (DFS)

Open the READ breakdown →